DavenportD.S., MasanariR.M., PfallerM.A., BaleM.J., HierholzerW.J.Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.J Infect Dis1986; 153: 332–9.
3.
KristinssonK.G., SpencerR.C., HastingsJ.G.M., BrownC.B.Slime production by coagulase negative staphylococci – a major virulence factor?Contrib Nephrol1987; 57: 79–84.
4.
AlexanderW., RimlandD.Lack of correlation of slime production with pathogenicity in continuous peritoneal dialysis peritonitis caused by coagulase negative staphylococci.Diagn Microbiol Infect Dis1987; 8: 215–20.
5.
KloosW.E., SchleiferK.H.Simplified scheme for routine identification of human Staphylococcus species.J Clin Microbiol1975; 1: 82–8.
6.
KloosW.E., BannermanT.L.Staphylococcus and Micrococcus. In: MurrayP.R., BaronE.J., PfallerM.A., TenoverF.C., YolkenR.H., eds. Manual of Clinical Microbiology.6th ed.Washington: American Society for Microbiology; 1995: 282–98.
7.
ChristensenG.D., SimpsonW.A., BisnoA.L., BeacheyE.H.Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.Infect Immun1982; 37: 318–26.
8.
National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial disk susceptibility tests.Villanova: NCCLS; 1998 (NCCLS document M2-A5): 32.
9.
GrayE.D., PetersG., VerstegenM., RegelmennW.E.Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response.Lancet1984; 1: 365–7.